Following an analysis of the literature, the review concludes that the recent huge increase in our theoretical knowledge of the molecular biology of the CEA family has been accompanied by an adequate practical immunohistological implementation. However, a broader use of CEA as a diagnostic tool has been hampered by variable and conflicting results using poly-clonal anti-CEA antibodies and by lack of standardization of immunohistochemical methods and tissue preparation. CEA immunoreactivity has been demonstrated in a variety of normal and neoplastic tissues, but in all sites with positive staining, at least one other author has failed to identify CEA reactivity. CEA can be used as a marker to identify epithelial differentiation; however, this will be helpful in only 1 % of cases. The introduction of well-defined monoclonal antibodies against clearly defined epitopes of the CEA family will make the differential diagnosis of tumors easier.

Keywords:
CEA, Diagnostic tool, Immunohistopathology
This content is only available via PDF.
© 1995 S. Karger AG, Basel
1995
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.